Ludovica Di Francesco

Dr. Ludovica Di Francesco

Department of Pediatrics, University of L'Aquila, Via Vetoio, 1. Coppito, L'Aquila, Italy.
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
AVAlberto Verrotti
Alberto Verrotti
GIGiulia Iapadre
Giulia Iapadre
LFLudovica Di Francesco
Ludovica Di Francesco
LZLuca Zagaroli
Luca Zagaroli
GFGiovanni Farello
Giovanni Farello
Epilepsy is a chronic and debilitating neurological disorder, with a worldwide prevalence of 0.5–1% and a lifetime incidence of 1–3%. An estimated 30% of epileptic patients continue to experience seizures throughout life, despite adequate drug therapy or surgery, with a major impact on society and global health. In recent decades, dietary regimens have been used effectively in the treatment of drug-resistant epilepsy, following the path of a non-pharmacological approach. The ketogenic diet and its variants (e.g., the modified Atkins diet) have an established role in contrasting epileptogenesis through the production of a series of cascading events induced by physiological ketosis. Other dietary regimens, such as caloric restriction and a gluten free diet, can also exert beneficial effects on neuroprotection and, therefore, on refractory epilepsy. The purpose of this review was to analyze the evidence from the literature about the possible efficacy of different dietary regimens on epilepsy, focusing on the underlying pathophysiological mechanisms, safety, and tolerability both in pediatric and adult population. We believe that a better knowledge of the cellular and molecular biochemical processes behind the anticonvulsant effects of alimentary therapies may lead to the development of personalized dietary intervention protocols.

Verified
Journal Article
Open access
PDF file
GSGiovanna Scorrano
Giovanna Scorrano
LFLudovica Di Francesco
Ludovica Di Francesco
ALArmando Di Ludovico
Armando Di Ludovico
FCFrancesco Chiarelli
Francesco Chiarelli
SMSara Matricardi
Sara Matricardi
Neurodevelopmental disorders (NDDs) are a group of conditions affecting brain development, with variable degrees of severity and heterogeneous clinical features. They include intellectual disability (ID), autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), often coexisting with epilepsy, extra-neurological comorbidities, and multisystemic involvement. In recent years, next-generation sequencing (NGS) technologies allowed the identification of several gene pathogenic variants etiologically related to these disorders in a large cohort of affected children. These genes encode proteins involved in synaptic homeostasis, such as SNARE proteins, implicated in calcium-triggered pre-synaptic release of neurotransmitters, or channel subunit proteins, such as post-synaptic ionotropic glutamate receptors involved in the brain’s fast excitatory neurotransmission. In this narrative review, we dissected emerged molecular mechanisms related to NDDs and epilepsy due to defects in pre- and post-synaptic transmission. We focused on the most recently discovered SNAREopathies and AMPA-related synaptopathies.

1 March 2019 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
AVAlberto Verrotti
Alberto Verrotti
LFLudovica Di Francesco
Ludovica Di Francesco
Pasquale StrianoPasquale Striano
Pasquale Striano

27 November 2023 in Genes
Verified
Journal Article
Open access
PDF file
AGAntonella Gambadauro
Antonella Gambadauro
GMGiuseppe Donato Mangano
Giuseppe Donato Mangano
KGKarol Galletta
Karol Galletta
FGFrancesca Granata
Francesca Granata
ARAntonella Riva
Antonella Riva
RCRoberto Chimenz
Roberto Chimenz
Pathogenic gene variants encoding nuclear pore complex (NPC) proteins were previously implicated in the pathogenesis of steroid-resistant nephrotic syndrome (SRNS). The NUP85 gene, encoding nucleoporin, is related to a very rare form of SRNS with limited genotype–phenotype information. We identified an Italian boy affected with an SRNS associated with severe neurodevelopmental impairment characterized by microcephaly, axial hypotonia, lack of achievement of motor milestones, and refractory seizures with an associated hypsarrhythmic pattern on electroencephalography. Brain magnetic resonance imaging (MRI) showed hypoplasia of the corpus callosum and a simplified gyration of the cerebral cortex. Since the age of 3 years, the boy was followed up at our Pediatric Nephrology Department for an SRNS, with a focal segmental glomerulosclerosis at renal biopsy. The boy died 32 months after SRNS onset, and a Whole-Exome Sequencing analysis revealed a novel compound heterozygous variant in NUP85 (NM_024844.5): 611T>A (p.Val204Glu), c.1904T>G (p.Leu635Arg), inherited from the father and mother, respectively. We delineated the clinical phenotypes of NUP85-related disorders, reviewed the affected individuals so far reported in the literature, and overall expanded both the phenotypic and the molecular spectrum associated with this ultra-rare genetic condition. Our study suggests a potential occurrence of severe neurological phenotypes as part of the NUP85-related clinical spectrum and highlights an important involvement of nucleoporin in brain developmental processes and neurological function.

17 August 2021
Verified
Preprint
Open access
PDF file
LFLudovica Di Francesco
Ludovica Di Francesco
EMEugenia Maranella
Eugenia Maranella
SFSandra Di Fabio
Sandra Di Fabio
FCFrancesco Chiarelli
Francesco Chiarelli
Cerebral sinovenous thrombosis (CSVT) is an uncommon neurological disease in newborns. Literature data report the association between prothrombotic risk factors and CSVT. This correlation can help the clinician make an earlier diagnosis of this subtle disease. Herein, we describe a severe neonatal CSVT in the absence of significant risk factors.